Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Journal of the American Academy of Dermatology (JAAD)
Published October 30, 2026
52-Week Safety and Disease Control With Ruxolitinib Cream in Children Aged 2 to 11 Years With Ato...
October 31, 2026
Medspoke
Medspoke
Journal of the American Academy of Dermatology (JAAD)
Published October 30, 2026
00:00
--:--
Intralesional cemiplimab for patients with early-stage cutaneous squamous cell carcinoma: Results...
October 31, 2026
Share
Intralesional cemiplimab for patients with early-stage cutaneous squamous cell carcinoma: Results from a dose-escalation study with expansion cohorts.
https://www.medspoke.co/channel_journal?id=875&tap_id=16803
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Seminars in Arthritis and Rheumatism
Published October 22, 2026
Cardiovascular outcomes and safety of SGLT2 inhibitors in rheumatic diseases: a systematic review...
October 31, 2026
Why are you reporting this TALK?